ํ๋ น์๋ฒค์๋ฏผ
ํ๋ น์๋ฒค์๋ฏผ์ ์ง์์ฑ, ๋น๊ฒฝ์์ **์ํ-์๋๋ ๋ ๋ฆฐ ์์ฉ์ฒด ๊ธธํญ์ **์ ๋๋ค. ์์ํ์์๋ ์ฃผ๋ก ๋ค์๊ณผ ๊ฐ์ ๋ชฉ์ ์ผ๋ก ์ฌ์ฉ๋ฉ๋๋ค: - **์๋๋ฌผ**: ๊ธฐ๋ฅ์ ์๋ ํ์ ๋๋ ๋ฐฐ๋จ๊ทผ ๋ฌด๋ฐ์ฌ๋ฅผ ์น๋ฃํ๊ธฐ ์ํด ๋ด๋ถ ์๋ ๊ด์ฝ๊ทผ์ ๊ธด์ฅ๋๋ฅผ ๋ฎ์ถฅ๋๋ค. ๋ํ **๊ฐ์์ธํฌ์ข ** ํ์์์ ์ข ์ ์์ ์ค ๋ฐ์ํ ์ ์๋ ์น๋ช ์ ์ธ ๊ณ ํ์ ์๊ธฐ๋ฅผ ์๋ฐฉํ๊ธฐ ์ํ ํ์์ ์ธ ์์ ์ ํฌ์ฌ ์ฝ๋ฌผ์ ๋๋ค. - **๋ง**: ์ด๊ธฐ ์ ์ฝ์ผ, ๋ถ๋น์ฑ ์ค์ฌ ๋ฐ ๋ฐฉ๊ด ๋ถ์ ๋ง๋น ๊ด๋ฆฌ๋ฅผ ํฌํจํ ํน์ ์ฉ๋๋ก ์ฌ์ฉ๋ฉ๋๋ค. > **์์ ์์ **: ํ๋ น์๋ฒค์๋ฏผ์ ์์ฉ์ฒด์ ๋น๊ฐ์ญ์ ์ผ๋ก ๊ฒฐํฉํ๊ธฐ ๋๋ฌธ์ ๊ทธ ํจ๊ณผ๊ฐ ์ค๋ ์ง์๋๋ฉฐ, ์๋ก์ด ์์ฉ์ฒด๊ฐ ํฉ์ฑ๋์ด์ผ๋ง ํจ๊ณผ๊ฐ ๋ฐ์ ๋ ์ ์์ต๋๋ค. ์ด ๊ณผ์ ์ ๋ฉฐ์น ์ด ์์๋ฉ๋๋ค.
์์ฉ ๊ธฐ์ : Phenoxybenzamine covalently and irreversibly binds to **alpha-1 and alpha-2 adrenergic receptors** โ non-competitive blockade of circulating epinephrine and norepinephrine โ profound vasodilation and relaxation of smooth muscle. - **Urinary Tract**: Blockade of alpha receptors in the trigone and internal urethral sphincter โ decreased urethral resistance โ facilitation of bladder emptying. - **Cardiovascular**: Blockade of vascular alpha receptors โ decreased peripheral vascular resistance โ lowered blood pressure (often causing reflex tachycardia). Because the binding is irreversible, the effect is often described as a 'chemical sympathectomy'. It has no effect on beta-adrenergic or parasympathetic receptors.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Functional urethral obstruction ยท 2.5-7.5 mg/cat ยท PO ยท once to twice daily
- Functional urethral obstruction ยท 1.25-7.5 mg (total dose) ยท PO ยท q12-24h
- Functional urethral obstruction ยท 2.5-10 mg (total dose) ยท PO ยท q24h
- Short-term treatment of hypertension ยท 0.5 mg/kg ยท PO ยท q12h
- Short-term treatment of hypertension ยท 2.5 mg (total dose) increasing by 2.5 mg up to a maximum of 10 mg (total dose) ยท PO ยท q12h
- Short-term treatment of hypertension ยท 2.5-7.5 mg per cat ยท PO ยท q8-12h
- Decrease urethral sphincter tone in bladder paresis ยท 0.7 mg/kg ยท PO ยท 4 times a day ยท Used in combination with bethanechol at 0.25-0.75 mg/kg PO 2-4 times a day.
- Adjunctive treatment of laminitis (developmental phase) ยท 1 mg/kg ยท IV ยท q12h ยท for 2 doses
- Treatment of profuse, watery diarrhea ยท 200-600 mg ยท q12h
- Functional urethral obstruction ยท 0.25 mg/kg ยท PO ยท q12-24h ยท Alternative dose: 2.5-20 mg (total dose) PO q12-24h
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Conditions where hypotension is undesirable (e.g., shock, unless fluid replacement is adequate)
- Horses with clinical signs of colic
- Glaucoma (relative contraindication)
- Diabetes mellitus (relative contraindication)
์ด์๋ฐ์
- Hypotension (postural/orthostatic)
- Hypertension (rebound)
- Miosis
- Increased intraocular pressure
- Tachycardia (reflex)
- Sodium retention
- Inhibition of ejaculation
- Nasal congestion
- Weakness or dizziness
- Gastrointestinal effects (nausea, vomiting)
- Constipation (specifically noted in horses)
- Hypotension
- Tachycardia
์ฝ๋ฌผ ์ํธ์์ฉ
- Epinephrine ยท Epinephrine reversal: If used with drugs that have both alpha- and beta-adrenergic effects, increased hypotension, vasodilation, or tachycardia may result due to unopposed beta effects.
- Phenylephrine ยท Phenoxybenzamine will antagonize the effects of alpha-adrenergic sympathomimetic agents.
- Reserpine ยท Phenoxybenzamine can antagonize the hypothermic effects of reserpine.
- Beta-blockers ยท Increased risk of first dose hypotensive effect; if used for phaeochromocytoma, beta-blockers must only be started after alpha blockade is in place to avoid hypertensive crisis. ยท major
- Diuretics ยท Increased risk of first dose hypotensive effect. ยท moderate
- Alpha-adrenergic sympathomimetics (e.g., phenylephrine) ยท Phenoxybenzamine will antagonize the effects of these agents. ยท major
๋ชจ๋ํฐ๋ง
- Clinical efficacy (e.g., adequate urination, ease of voiding)
- Blood pressure (monitor for hypotension)
- Heart rate (monitor for reflex tachycardia)
- Blood pressure
- Heart rate and rhythm
- Urine output and ease of urination
๊ณผ์ฉ๋
Overdosage may yield signs of **postural hypotension** (dizziness, syncope), tachycardia, vomiting, lethargy, or shock. **Treatment**: - Empty the gut if ingestion was recent and there are no contraindications. - Treat hypotension with aggressive intravenous fluid support. - **DO NOT USE EPINEPHRINE** (causes paradoxical further drop in blood pressure due to unopposed beta-adrenergic vasodilation). - Most standard vasopressors are ineffective due to the alpha-blockade. Intravenous norepinephrine (levarterenol) may be beneficial if clinical signs are severe.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.